Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Shares Outstanding (2016 - 2026)

Pharma-Bio Serv's Shares Outstanding history spans 17 years, with the latest figure at $23.5 million for Q1 2026.

  • For Q1 2026, Shares Outstanding changed 0.0% year-over-year to $23.5 million; the TTM value through Jan 2026 reached $23.5 million, changed 0.0%, while the annual FY2025 figure was $23.5 million, 0.0% changed from the prior year.
  • Shares Outstanding reached $22.9 million in Q1 2026 per PBSV's latest filing, down from $23.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $23.5 million in Q1 2024 to a low of $22.9 million in Q1 2026.
  • Average Shares Outstanding over 5 years is $23.5 million, with a median of $23.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: increased 0.24% in 2023, then changed 0.0% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $23.5 million in 2022, then increased by 0.24% to $23.5 million in 2023, then rose by 0.03% to $23.5 million in 2024, then changed by 0.0% to $23.5 million in 2025, then changed by 0.0% to $23.5 million in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Shares Outstanding are $23.5 million (Q1 2026), $23.5 million (Q4 2025), and $23.5 million (Q3 2025).